Analysts See $-0.17 EPS for Calyxt, Inc. (CLXT); Alyeska Investment Group LP Has Increased By $36.01 Million Its Citigroup (C) Position

January 14, 2018 - By Peter Kolinski

Alyeska Investment Group Lp increased Citigroup Inc (C) stake by 63.34% reported in 2017Q3 SEC filing. Alyeska Investment Group Lp acquired 500,139 shares as Citigroup Inc (C)’s stock rose 1.55%. The Alyeska Investment Group Lp holds 1.29M shares with $93.81 million value, up from 789,560 last quarter. Citigroup Inc now has $203.17B valuation. The stock increased 1.69% or $1.28 during the last trading session, reaching $76.84. About 16.95 million shares traded or 12.74% up from the average. Citigroup Inc. (NYSE:C) has risen 35.60% since January 14, 2017 and is uptrending. It has outperformed by 18.90% the S&P500.

Analysts expect Calyxt, Inc. (NASDAQ:CLXT) to report $-0.17 EPS on February, 12.After having $-0.51 EPS previously, Calyxt, Inc.’s analysts see -66.67% EPS growth. The stock increased 1.17% or $0.27 during the last trading session, reaching $23.39. About 33,238 shares traded. Calyxt, Inc. (NASDAQ:CLXT) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 3 analysts covering Calyxt Inc (NASDAQ:CLXT), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Calyxt Inc had 4 analyst reports since August 14, 2017 according to SRatingsIntel. The company was initiated on Monday, August 14 by Wells Fargo. Citigroup downgraded the shares of CLXT in report on Wednesday, September 27 to “Hold” rating. As per Monday, August 14, the company rating was initiated by Jefferies. The firm has “Buy” rating given on Tuesday, August 15 by Citigroup.

Calyxt, Inc., an agriculture biotechnology company, develops healthier specialty food ingredients and agricultural food crops using gene editing technology for plants. The company has market cap of $647.74 million. It engages in the development of high oleic soybeans, powdery mildew resistant wheat, cold storable potatoes, high fiber wheat, reduced browning potatoes, and herbicide tolerant wheat. It currently has negative earnings. The Firm was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015.

Among 38 analysts covering Citigroup Inc. (NYSE:C), 19 have Buy rating, 3 Sell and 16 Hold. Therefore 50% are positive. Citigroup Inc. had 108 analyst reports since July 21, 2015 according to SRatingsIntel. Atlantic Securities upgraded Citigroup Inc. (NYSE:C) on Wednesday, December 21 to “Overweight” rating. Citigroup maintained the stock with “Buy” rating in Monday, October 9 report. Deutsche Bank maintained Citigroup Inc. (NYSE:C) on Wednesday, August 12 with “Hold” rating. The stock of Citigroup Inc. (NYSE:C) has “Buy” rating given on Tuesday, December 12 by Keefe Bruyette & Woods. RBC Capital Markets maintained it with “Outperform” rating and $79 target in Friday, October 13 report. The stock of Citigroup Inc. (NYSE:C) earned “Hold” rating by Jefferies on Friday, July 7. The firm has “Outperform” rating by Macquarie Research given on Friday, November 10. The firm has “Sell” rating by Societe Generale given on Monday, October 16. The firm has “Hold” rating by Jefferies given on Monday, November 28. The rating was maintained by Wells Fargo with “Buy” on Monday, October 2.

Alyeska Investment Group Lp decreased Brookdale Sr Living Inc (NYSE:BKD) stake by 314,312 shares to 574,115 valued at $6.09M in 2017Q3. It also reduced Kkr Real Estate Fin Tr Inc stake by 88,197 shares and now owns 111,803 shares. Box Inc was reduced too.

Since August 4, 2017, it had 0 buys, and 2 selling transactions for $3.05 million activity. Aristeguieta Francisco also sold $2.70 million worth of Citigroup Inc. (NYSE:C) on Thursday, August 10. 5,000 shares were sold by WALSH JEFFREY R, worth $344,870 on Friday, August 4.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>